Skip to content
★ Sign in to follow
Clarity Medical Group Holding Ltd. logo

Clarity Medical Group Holding Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$191.6MHealth Care

No insider purchase over the last 90 days. The latest, by Hui Yung Chris, was filed 12 Oct 2023.

Clarity Medical Group Holding Ltd.: what insiders have been doing

Clarity Medical Group Holding Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. 1 insider has disclosed 1 filing since 22 October 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

Over the last twelve months, not one insider purchase of Clarity Medical Group Holding Ltd. stock was filed.

Across the 1,314 companies tracked on its exchange, the median is 4 filings; at 1 filing, this issuer sits below that mark. Looking back to 2022, when coverage begins, insiders filed 17 purchases and 29 sales.

This summary is built from HKEX disclosures alone and does not predict where the share price will go.

Insider Decl.
76
Thresholds
n/a
Buy Volume
€299,616
17 ops. · all time
Sell Volume
€4M
29 ops. · all time

Since the insiders bought

  • Filed 27 Apr 2023 · 1292 days ago · €68k
    -56.5%
    Entry HK$1.24 · Close at T+365 HK$0.54

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,719 of 26,913 companies
23.7
score / 100
Value
11
Quality
36
FCF yld-15%
Earn yld-24%
EV/EBITDA·
ROE-33%
Gross mgn80%
Net mgn-26%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2024

FY ended March 2024 · cache

HK$0.36
Analyst consensus
·
Income statement
RevenueHK$190.9M
Gross profitHK$153.6M80% margin
EBITDA-HK$42.5M-22% margin
Net income-HK$75.8M-26.1% margin
Valuation
P/Book1.6x
Beta0.54
Balance sheet & cash
Market capHK$191.6M
Total debtHK$25.4M
Free Cash Flow-HK$48.4M
Debt / Equity24%
Profitability & ownership
ROE-33.3%
ROA-16.7%
% insiders66.3%
% institutions0.0%
Last declaration on 16 September 2026
Declarations76 total
  • ●
    DirectorExecutives
    19M HKD19HKEX
    41,820,000 shares@ HK$0.45100.0% of flowShareXHKGHKEX:DA20260915E00504
  • ●
    DirectorExecutives
    0HKEX
    5,000,000 shares0ShareXHKGHKEX:DA20250704E00441
  • ●
    DirectorExecutives
    0HKEX
    35,313 sharesShareXHKGHKEX:DA20240705E00068
  • ▼
    DirectorExecutives
    3M HKD13HKEX
    7,000,000 shares@ HK$0.46817.1% of flowShareXHKGHKEX:DA20240326E00201
  • ▼
    DirectorExecutives
    3M HKD13HKEX
    5,577,500 shares@ HK$0.5415.7% of flowShareXHKGHKEX:DA20240322E00175
  • ▼
    DirectorExecutives
    6M HKD14HKEX
    10,272,500 shares@ HK$0.54629.3% of flowShareXHKGHKEX:DA20240319E00213
  • ▼
    DirectorExecutives
    156,657 HKD11HKEX
    357,500 shares@ HK$0.43820.8% of flowShareXHKGHKEX:DA20240312E00059
  • ▼
    DirectorExecutives
    482,500 HKD11HKEX
    965,000 shares@ HK$0.502.5% of flowShareXHKGHKEX:DA20240205E00071
  • ▼
    DirectorExecutives
    63,225 HKD11HKEX
    112,500 shares@ HK$0.5620.3% of flowShareXHKGHKEX:DA20240129E00183
  • ▼
    DirectorExecutives
    2M HKD12HKEX
    3,276,250 shares@ HK$0.607510.4% of flowShareXHKGHKEX:DA20240123E00328
  • ▼
    DirectorExecutives
    2M HKD12HKEX
    3,125,000 shares@ HK$0.6410.4% of flowShareXHKGHKEX:DA20231205E00212
  • ▲
    DirectorExecutives
    0HKEX
    5,000,000 shares0ShareXHKGHKEX:DA20231012E00166
    Canonical exit: 2 Oct 2023 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    141,250 shares0ShareXHKGHKEX:DA20231012E00158
    Canonical exit: 2 Oct 2023 (T+90)
  • ▲
    DirectorExecutives
    589,495 HKD11HKEX
    496,250 shares@ HK$1.18793.0% of flowShareXHKGHKEX:DA20230427E00366
    Canonical exit: 25 Jul 2023 (T+90)
  • ●
    DirectorExecutives
    0HKEX
    50,937,500 sharesShareXHKGHKEX:DA20230426E00063
  • ●
    DirectorExecutives
    1M HKD17HKEX
    1,850,000 shares@ HK$0.5758.8% of flowShareXHKGHKEX:DA20221229E00229
  • ●
    DirectorExecutives
    3M HKD19HKEX
    4,500,000 shares@ HK$0.57100.0% of flowShareXHKGHKEX:DA20221229E00216
  • ▲
    DirectorExecutives
    1,488 HKD11HKEX
    1,250 shares@ HK$1.190.0% of flowShareXHKGHKEX:DA20221013E00433
    Canonical exit: 8 Jan 2023 (T+90)
  • ▲
    DirectorExecutives
    110,476 HKD11HKEX
    95,000 shares@ HK$1.16290.6% of flowShareXHKGHKEX:DA20221007E00051
    Canonical exit: 3 Jan 2023 (T+90)
  • ▲
    DirectorExecutives
    349,711 HKD11HKEX
    310,000 shares@ HK$1.12812.0% of flowShareXHKGHKEX:DA20221005E00143
    Canonical exit: 28 Dec 2022 (T+90)
  • ▲
    DirectorExecutives
    1,375 HKD11HKEX
    1,250 shares@ HK$1.100.0% of flowShareXHKGHKEX:DA20220928E00082
    Canonical exit: 22 Dec 2022 (T+90)
  • ▲
    DirectorExecutives
    58,988 HKD11HKEX
    41,250 shares@ HK$1.430.3% of flowShareXHKGHKEX:DA20220902E00266
    Canonical exit: 28 Nov 2022 (T+90)
  • ▲
    DirectorExecutives
    88,098 HKD11HKEX
    60,000 shares@ HK$1.46830.5% of flowShareXHKGHKEX:DA20220826E00239
    Canonical exit: 21 Nov 2022 (T+90)
  • ▲
    DirectorExecutives
    735,200 HKD11HKEX
    500,000 shares@ HK$1.47044.2% of flowShareXHKGHKEX:DA20220825E00355
    Canonical exit: 20 Nov 2022 (T+90)
  • ▲
    DirectorExecutives
    24,200 HKD11HKEX
    20,000 shares@ HK$1.210.1% of flowShareXHKGHKEX:DA20220816E00083
    Canonical exit: 10 Nov 2022 (T+90)

25 of 76 declarations

About Clarity Medical Group Holding Ltd.

Clarity Medical Group Holding Ltd. is a company focused on the medical sector, providing innovative services and solutions. It aims to enhance healthcare through technology and medical expertise.